Pulmonary embolism registry Freiburg - Retrospective analysis of safety and efficacy of treatment regimen in acute pulmonary embolism - especially of lysis therapy in patients at intermediate risk

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

DRKS

Registry ID

DRKS00023368

Enrollment

400

Registered

2020-10-19

Start date

2020-10-16

Completion date

Unknown

Last updated

2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

I26.0 I26.9

Interventions

Group 1: Patients with pulmoary embolism, receiving thrombolysis as therapy Group 2: Parients with pulmoary embolism, receiving anticoagulation as therapie

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: pulmonary embolism and inpatient treatment

Exclusion criteria

Exclusion criteria: none

Design outcomes

Primary

Measure	Time frame
In-hospital mortality	—

Secondary

Measure	Time frame
Bleeding recurrent pulmonary embolsim days on ICU days of ventilation days in hospital	—

Countries

Germany

Contacts

Public ContactNadine Gauchel

Universitäts-Herzzentrum Freiburg -- Bad Krozingen Kardiologie und Angiologie I

nadine.gauchel@universitaets-herzzentrum.de0761/27034010

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026